Astrazeneca, Moderna most advanced in COVID-19 vaccine race - WHO
The British drugmaker has already begun large-scale, mid-stage human trials of the vaccine, which was developed by researchers at University of Oxford.
The logo of AstraZeneca is seen on a medication package in a pharmacy in London April 28, 2014(photo credit: STEFAN WERMUTH/REUTERS)ByREUTERS
